Sedat Biter

16PUBLICATIONS

203CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesInnate immunityOptical technology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jul 15, 2026

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 12, 2026

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 27, 2026

Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study.

|May 08, 2026

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

Pageof 3

Frequent Collaborators

Elif Sahin

Nargiz Majidova

Ertugrul Bayram

Deniz Can Guven

Mehmet Mutlu Kıdı

Teoman Sakalar

Hayati Arvas

Anıl Karakayali

Mustafa Seyyar

Havva Yesil Cinkir

Frequent Collaborators

Elif Sahin

Nargiz Majidova

Ertugrul Bayram

Deniz Can Guven